Belvedere Trading LLC Summit Therapeutics Inc. Put Options Transaction History

Belvedere Trading LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Oct 30, 2024	BUY	$6.89 - $31.93 $125,398 - $581,126	18,200 Added 1516.67%	19,400 $424,000
Q2 2024 Nov 01, 2024	SELL	$2.39 - $10.92 $43,498 - $198,744	-18,200 Reduced 93.81%	1,200 $9,000
Q2 2024 Aug 09, 2024	BUY	$2.39 - $10.92 $2,868 - $13,104	1,200 New	1,200 $9,000
Q4 2023 Feb 13, 2024	SELL	$1.67 - $2.83 $2,338 - $3,962	-1,400 Reduced 32.56%	2,900 $7,000
Q3 2023 Oct 27, 2023	BUY	$1.54 - $2.42 $154 - $242	100 Added 2.38%	4,300 $8,000
Q2 2023 Aug 08, 2023	BUY	$1.32 - $2.81 $1,980 - $4,215	1,500 Added 55.56%	4,200 $10,000
Q1 2023 May 15, 2023	BUY	$1.38 - $5.41 $3,725 - $14,607	2,700 New	2,700 $4,000

193

75.8M

2.01M

2.84M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.82B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.